Press release
Rising Cancer Rates and Technological Innovation Drive Exosomes Market to USD 900 Million by 2029
Mordor Intelligence has published a new report on the Exosomes Market, offering a comprehensive analysis of trends, growth drivers, and future projections.The Exosomes Market is projected to be valued at USD 429.9 million in 2024 and is anticipated to grow to USD 900 million by 2029, registering a Compound Annual Growth Rate (CAGR) of 15.92% during the forecast period (2024-2029). The factors driving market growth include the rising prevalence of cancer, advancements in exosome isolation and analytical technologies, and the expanding advanced applications of exosomes.
Report Overview - https://www.mordorintelligence.com/industry-reports/exosomes-market
Key Trends Drives the Exosomes Market
Increasing Cancer Prevalence
The rising incidence of cancer globally has heightened the demand for innovative diagnostic and therapeutic solutions. Exosomes, as extracellular vesicles involved in cell communication, have emerged as potential biomarkers for cancer detection and prognosis. According to the GLOBOCAN 2020 report, approximately 19.29 million people were living with cancer, a number expected to rise over the next two decades. This surge underscores the critical role of exosomes in cancer management, thereby driving market growth.
Technological Advancements in Exosome Isolation and Analysis
Recent technological innovations have significantly enhanced the efficiency and accuracy of exosome isolation and analysis. Advanced techniques such as ultracentrifugation, microfluidics, and immunoaffinity capture have streamlined the isolation process, facilitating more precise diagnostic applications. These advancements have broadened the scope of exosome research, enabling their use in various therapeutic areas and contributing to market expansion.
Expanding Applications in Diagnostics and Therapeutics
Exosomes have garnered substantial interest for their potential in diagnostics and therapeutics, particularly in oncology. Their ability to carry molecular information between cells makes them valuable in non-invasive liquid biopsies and targeted drug delivery systems. Ongoing research and clinical trials are exploring exosome-based therapies, further propelling their adoption in personalized medicine and enhancing market growth.
Market Segmentation
The exosomes market is segmented based on product, application, and geography:
By Product:
Kits and Reagents
Instruments
Services
By Application:
Cancer
Neurodegenerative Diseases
Cardiovascular Diseases
Infectious Diseases
Other Applications
By Geography:
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Among these segments, the cancer application is expected to dominate the market due to the high prevalence of the disease and the critical role of exosomes in cancer diagnostics and therapeutics. Geographically, North America holds the largest market share, attributed to robust research activities and the presence of key industry players.
Get a Customized Report Tailored to Your Requirements. - https://www.mordorintelligence.com/market-analysis/genomics
Key Players
The exosomes market is characterized by the presence of several key players actively engaged in research and development:
Diagenode Inc.
Hitachi Chemical Diagnostics Inc.
Qiagen
Thermo Fisher Scientific Inc.
Danaher (Beckman Coulter Inc.)
These companies are focusing on strategic collaborations, product innovations, and expanding their global footprint to strengthen their market position. Their efforts are pivotal in advancing exosome technologies and applications, thereby contributing to market growth.
Conclusion
The global exosomes market is on a robust growth trajectory, driven by the increasing prevalence of cancer, technological advancements in exosome isolation and analysis, and expanding applications in diagnostics and therapeutics. As research progresses and new clinical applications emerge, exosomes are set to play a transformative role in personalized medicine, offering promising avenues for early disease detection and targeted therapies. With continued innovation and strategic industry efforts, the market is expected to reach USD 900.03 million by 2029, marking a significant advancement in the biomedical field.
Industry Related Reports:
Fetal Bovine Serum Market: The report highlights the Global Fetal Bovine Serum Market Growth Factors and Manufacturers, segmented by Application (Biopharmaceuticals, Cell Culture Media, Human and Animal Vaccine Production, and Other Applications), Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, and Other Products), End User (Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/fetal-bovine-serum-market
Pharmaceutical CDMO Market: The report highlights the Global Contract Development and Manufacturing Organization (CDMO) Market Share by Company. It is segmented by Service Type into the CMO Segment (Active Pharmaceutical Ingredient (API) Manufacturing, including Small Molecule, Large Molecule, and High Potency (HPAPI); Finished Dosage Formulation (FDF) Development and Manufacturing, covering Solid Dose Formulation (Tablets), Liquid Dose Formulation, and Injectable Dose Formulation; and Secondary Packaging) and the CRO Segment (Research Phase, including Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV). Geographical segmentation for the Pharmaceutical CMO includes North America (United States and Canada), Europe (United Kingdom, Germany, France, Italy, and the Rest of Europe), Asia-Pacific (China, India, Japan, Australia, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), and the Middle East and Africa (United Arab Emirates, Saudi Arabia, South Africa, and the Rest of the Middle East and Africa).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/pharmaceutical-contract-development-and-manufacturing-organization-cdmo-market
Plant Stem Cell Market: The Plant Stem Cell Market is categorized by Location (Root Apical Meristems, Shoot Apical Meristems, and Vascular Meristems), Application (Nutrition, Pharmaceuticals, and Cosmetics), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/plant-stem-cell-market
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Cancer Rates and Technological Innovation Drive Exosomes Market to USD 900 Million by 2029 here
News-ID: 3762516 • Views: …
More Releases for Exosome
Emerging Trends Exosome Diagnostics and Therapeutics Market Dominated by Evox Th …
An exosome diagnostic and therapeutic study approach represents the opportunity to expand and develop the liquid biopsy market, a growing sector in cancer diagnostics. Once they reach the recipient cells, cytoplasmic ingredients can alter their biology.
Access Sample Papers of Exosome Diagnostics and Therapeutics Market with 248 Pages and 6 Company Profiles Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1529771 .
Growth in exosome diagnostic and therapeutic market in these regions attributes to the technological advancement in…
Exosome Diagnostic Market 2025 SWOT Analysis by Top Key Players-Aethlon Medical, …
Exosome Diagnostic Software market size estimations have been provided in terms of value (USD million). The Global Exosome Diagnostic Software industry report also identifies major market players and provides analysis in terms of company overview, financials, products & services, market trends, recent developments and growth strategies.
Get Sample Copy of this Report @ https://www.orianresearch.com/request-sample/566927
Exosome Diagnostic Market report offers a comprehensive insight into the development policies and plans in addition to manufacturing…
Exosome Diagnostic and Therapeutic Market is expected to reach $368 million by 2 …
Exosome Diagnostic and Therapeutic Market was valued at $39 million, and is expected to reach $368 million by 2022, supported by a CAGR of 37.8%.
Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body. In addition, exosomes also stimulate the angiogenesis and migration leading to…
Exosome Diagnostic and Therapeutic Market – Qualitative Outlook On Growth 2025 …
Global Exosome Diagnostic and Therapeutic Market: Snapshot
The demand for diagnostic and therapeutic of exosome is projected to increment at a substantial CAGR during the forecast period of 2016 to 2024, gaining traction from a number of factors such as increasing prevalence of cancer, technological advancements in exosome isolation and pertaining analytical procedures, multiple awareness initiatives implemented by the government and healthcare organizations in various developed and emerging economies, and innovative…
Exosome Diagnostic and Therapeutic Market key players 2016 - 2024 : System Biosc …
Global Exosome Diagnostic and Therapeutic Market: Snapshot
The demand for diagnostic and therapeutic of exosome is projected to increment at a substantial CAGR during the forecast period of 2016 to 2024, gaining traction from a number of factors such as increasing prevalence of cancer, technological advancements in exosome isolation and pertaining analytical procedures, multiple awareness initiatives implemented by the government and healthcare organizations in various developed and emerging economies, and innovative…
Exosome Diagnostic and Therapeutics Market Size By 2027 | Thermo Fisher Scientif …
Future Market Insights in its recent research report titled “Exosome Diagnostic and Therapeutics Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” covers several factors that are influencing the robust growth of the global market. As per this research report, the global exosome diagnostic and therapeutic market is projected to expand at a high CAGR of 23.1% during the period of assessment. The exhaustive research publication includes key trends, opportunities,…